4.5 Review

Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis

Related references

Note: Only part of the references are listed.
Review Immunology

Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE

Luc Van Kaer et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

MicroRNA expression studies: challenge of selecting reliable reference controls for data normalization

Soheil Madadi et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Review Immunology

Impact of B cells to the pathophysiology of multiple sclerosis

Borros M. Arneth

JOURNAL OF NEUROINFLAMMATION (2019)

Article Immunology

miR-191 modulates B-cell development and targets transcription factors E2A, Foxp1, and Egr1

Jonas Blume et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis

Anuj et al.

MOLECULAR AND CELLULAR BIOLOGY (2019)

Review Medicine, Research & Experimental

Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis

Sanam Dolati et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biotechnology & Applied Microbiology

miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R

Na Liu et al.

ONCOTARGETS AND THERAPY (2018)

Article Medicine, Research & Experimental

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice

Yuan Xia et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Multidisciplinary Sciences

Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis

Camille A. Juzwik et al.

SCIENTIFIC REPORTS (2018)

Review Endocrinology & Metabolism

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Jacob O'Brien et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Review Clinical Neurology

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks

Barry A. Singer

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)

Article Multidisciplinary Sciences

Exosomal microRNA signatures in multiple sclerosis reflect disease status

Saeideh Ebrahimkhani et al.

SCIENTIFIC REPORTS (2017)

Article Neurosciences

Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy

Dhanashri P. Miskin et al.

JOURNAL OF NEUROVIROLOGY (2016)

Review Immunology

The role of microRNAs in the pathogenesis of autoimmune diseases

Ji-Qing Chen et al.

AUTOIMMUNITY REVIEWS (2016)

Review Medicine, Research & Experimental

Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review

Magdalena J. Kacperska et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)

Article Clinical Neurology

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis

Petra Bergman et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)

Article Multidisciplinary Sciences

miR-15b/16-2 deletion promotes B-cell malignancies

Francesca Lovat et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Clinical Neurology

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

Jens Ingwersen et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Review Medicine, General & Internal

Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis

Xinting Ma et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)

Review Pharmacology & Pharmacy

MicroRNAs and multiple sclerosis: from physiopathology toward therapy

Ameneh Zare-Shahabadi et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2013)

Article Medical Laboratory Technology

MicroRNA regulation of integrins

Weiguo Chen et al.

TRANSLATIONAL RESEARCH (2013)

Article Pharmacology & Pharmacy

Network Analysis of Randomized Controlled Trials in Multiple Sclerosis

Elias Zintzaras et al.

CLINICAL THERAPEUTICS (2012)

Article Immunology

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

Markus C. Kowarik et al.

JOURNAL OF NEUROINFLAMMATION (2012)

Article Clinical Neurology

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis

Luca Prosperini et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)

Article Biochemistry & Molecular Biology

Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus

Yao Yuan et al.

MOLECULAR IMMUNOLOGY (2012)

Article Medicine, General & Internal

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Gary Bloomgren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Microbiology

Virus-Encoded microRNAs: An Overview and a Look to the Future

Rodney P. Kincaid et al.

PLOS PATHOGENS (2012)

Article Multidisciplinary Sciences

Functional delivery of viral miRNAs via exosomes

D. Michiel Pegtel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Clinical Neurology

The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies

Michael K. Racke

CURRENT OPINION IN NEUROLOGY (2008)

Article Virology

Evolutionarily Conserved Function of a Viral MicroRNA

G. J. Seo et al.

JOURNAL OF VIROLOGY (2008)

Article Medicine, General & Internal

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

CH Polman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

RA Rudick et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)